-
1 Comment
JMDC Inc is currently in a long term downtrend where the price is trading 54.5% below its 200 day moving average.
From a valuation standpoint, the stock is 72.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 19.3.
JMDC Inc's total revenue rose by 63.1% to $5B since the same quarter in the previous year.
Its net income has increased by 62.3% to $849M since the same quarter in the previous year.
Finally, its free cash flow fell by 67.2% to $498M since the same quarter in the previous year.
Based on the above factors, JMDC Inc gets an overall score of 3/5.
Sector | Healthcare |
---|---|
Industry | Health Information Services |
Exchange | TSE |
CurrencyCode | JPY |
ISIN | JP3386690006 |
PE Ratio | 36.42 |
---|---|
Market Cap | 210B |
Beta | 0.53 |
Target Price | 5102.727 |
Dividend Yield | 1.0% |
JMDC Inc. provides medical statistics data services in Japan. The company offers medical field big data services; life insurance field big data services; support services for health insurance associations and local government health services; health data platform; and medical institution support services. It serves health insurance unions, pharmaceutical companies, life and non-life insurance companies, research institutions, etc. JMDC Inc. was incorporated in 2002 and is headquartered in Tokyo, Japan. As of October 10, 2023, JMDC Inc. operates as a subsidiary of OMRON Corporation.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4483.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025